Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Cancer Research Technology

Oncology-focused development and commercialisation company

The company in detail

Profile

Cancer Research Technology (CRT) is an oncology-focused development and commercialisation company that realises cancer patient benefit from publicly-funded research worldwide.

At CRT we bridge the fundamental gap between cutting edge academic research and industrial development of cancer therapeutics and diagnostics. We achieve this by working closely with prestigious international research institutes and funding bodies to develop, protect and commercialise oncology related discoveries. Core activities of business development and drug discovery are supported by specialist, integrated teams of patent, legal, finance and marketing personnel. Our exclusive focus in oncology provides for an unrivalled depth of knowledge and experience in cancer-specific translational development and commercialisation.

CRT is wholly owned by the charity Cancer Research UK, the largest independent funder of cancer research in the world. All proceeds are shared with inventors and their institutions, whilst profits are returned to Cancer Research UK to support further cancer research. The company is well resourced to achieve its mission, with its headquarters and an established R&D facility in London, and a US subsidiary in Boston.

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Deals

To view this information, you must subscribe to Partneringtools.

Latest News

To view this information, you must subscribe to Partneringtools.

Press Releases

(28th Aug 2007) CRT Begins Critical Role in New Australian Cancer Research Venture More
(21st Aug 2007) CRT Establishes Crystallography Facility at Birkbeck, University of London More
(17th Jul 2007) CRT and The Beatson Institute Announce Research Collaboration in Tumour Imaging with AstraZeneca More
(11th Jul 2007) Abiogen Licenses RFB4 Antibody from Cancer Research Technology More
(22nd Jun 2007) Cambridge Scientist Wins Innovation Award for Cancer Diagnostic Markers More
(20th Jun 2007) Cancer Research Technology Licenses Novel Toll-like Receptor Agents to Innate Pharma More
(4th Jun 2007) ondon, UK: 4th June 2007 - Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, and The University of Manchester today announce the establishment of an alliance with AstraZeneca. More
(14th May 2007) Cancer Research Technology & Cronos Therapeutics Extend Scope of Agreement More
(7th May 2007) Cancer Research Technology plans to expand Development Laboratories More
(2nd May 2007) Cancer Research Technology Licenses Therapeutic Antibodies to Peptech More
(19th Apr 2007) Antisoma Announces Global Agreement with Novartis for Cancer Drug AS1404 More
(2nd Apr 2007) New CEO to Spearhead Laboratory Expansion at Cancer Research Technology More
(1st Mar 2007) Fox Chase Cancer Center and Cancer Research Technology Inc. Initiate Drug Discovery Collaboration More
(27th Feb 2007) Cancer Research Technology Secure Orphan Drug Designation for Fenretinide on Behalf of Cancer Research UK More
(5th Feb 2007) Cancer Research Technology Grants Waypharm S.A.S Option to Novel Platinum Agents More
(30th Jan 2007) Formation of Australia's First Cooperative Enterprise Dedicated to the Development of New Cancer Therapies More
(11th Jan 2007) Cancer Research Technology Announce Milestone following Initiation of Stimuvax® Phase 3 Trial in Non Small Cell Lung Cancer More
(11th Dec 2006) Cancer Research Technology and The Institute of Cancer Research Receive Milestone Payment Related to Vernalis' Hsp90 Programme More
(20th Nov 2006) Cancer Research Technology and The University of Manchester Announce Clinical Pharmacology Collaboration in Oncology with AstraZeneca More
(6th Nov 2006) Cancer Research Technology to Present Discovery Updates at BioEurope 2006 More
(27th Sep 2006) Cancer Research Technology Grants Geneservice Ltd. Distribution Rights of RNA Interference Library Generated at the Netherlands Cancer Institute More
(7th Sep 2006) Nanoparticle-based PDT Collaboration Focuses on Proof of Concept Studies More
(4th Sep 2006) Cancer Research Technology Announce Colorectal Cancer Research Collaboration with AstraZeneca More
(14th Aug 2006) Leading Research Institutes Develop DamID: a Novel Protein-Genome Interaction Mapping Technology More
(10th Aug 2006) J. Barrie Ward to Strengthen CRT's Board of Directors More
(26th Jul 2006) Cancer Research Technology Announce Collaboration with Hammersmith Hospital to develop High Intensity Focused Ultrasound for the Treatment of Cancer More
(3rd May 2006) Cancer Research UK and Cancer Research Technology Unveil Plans to Revive Shelved Anti-Cancer Drugs More
(19th Apr 2006) Pharminox signs option to in-license novel telomere signalling targeted agents from Cancer Research Technology More
(11th Apr 2006) Cancer Research Technology Establishes US Subsidiary and Announces Recruitment of Managing Director More
(29th Mar 2006) Cancer Research Technology Announces Recruitment of Prof. Lloyd Kelland as Head of Biology More
(27th Mar 2006) Cronos Therapeutics and Cancer Research Technology Announce New Anti-cancer Drug Development Collaboration More
(15th Feb 2006) Stealthyx Therapeutics and Cancer Research Technology Announce Co-development Partnership for Tumour-targeted Therapy More
(7th Feb 2006) The University of Barcelona and Cancer Research Technology Partner for AT514 Drug Development Collaboration More
(19th Jan 2006) Galapagos and Cancer Research Technology Announce New Anti-Cancer Drug Discovery Collaboration More
(28th Nov 2005) Spear Therapeutics Raise $8.5 Million to Fund Cancer Drug Development More
(8th Nov 2005) The Norwegian Radium Hospital Research Foundation and Cancer Research Technology form a strategic alliance More
(26th Sep 2005) CellCentric and Cancer Research Technology initiate co-development partnership More
(20th Sep 2005) MerLion Pharmaceuticals Pte Ltd and Cancer Research Technology Announce Drug Discovery Collaboration More
(22nd Aug 2005) Minichromosome Maintenance Proteins Developed as Markers of a Series of Cancers at the University of Cambridge in Studies Funded by Cancer Research UK and the Medical Research Council More
(16th Jun 2005) Alnylam and CRT Report Grant of Fundamental RNAi Patent by the European Patent Office More
(10th May 2005) Dr Phil L'Huillier appointed as Director of Business Management at Cancer Research Technology More
(9th May 2005) Viragen Licenses 'Anti-CD55 Antibody' Cancer Therapy from Cancer Research Technology More
(26th Apr 2005) Ikonisys Inc. Enters into a Research Collaboration and Option Agreement with Cancer Research Technology Covering Automated Microscopy and Rare Cell Diagnostics in Cancer More
(23rd Mar 2005) Cancer Research Technology Ltd. (CRT) and Genvax, the MMI biobaby focused on cancer vaccines, announced today that they have concluded an exclusive worldwide licence for the commercialisation rights to a novel DNA vaccine portfolio More
(16th Feb 2005) The University of Cambridge, Cancer Research Technology, Cancer Research UK and Perlegen Sciences Collaborate to Analyse Thousands of DNA Samples from Breast Cancer Patients More
(1st Dec 2004) Cancer Research Technology grants AstraZeneca an exclusive license to a key patent in the field of nuclear receptors More
(2nd Nov 2004) Marie Curie Cancer Care and Cancer Research Technology extend relationship for cancer patient benefit More
(29th Sep 2004) Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis More
(11th Aug 2004) Availability of free licences of European patents on the hereditary breast cancer gene BRCA2 to publicly funded research laboratories and not-for-profit research laboratories. More
(20th Jul 2004) Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target More

Senior management

To view this information, you must subscribe to Partneringtools.

Board of directors

To view this information, you must subscribe to Partneringtools.

Head office

Cancer Research Technology
Sardinia House,
Sardinia Street
London
WC2A 3NL
United Kingdom

Tel:  +44 (0)207 269 3640
Fax: +44 (0)207 269 3641
www

Contact details

Dr Phil L'Huillier
Director of Business Management
Request more information
Mrs Amy Francis
Administrator
Request more information

Company figures

Formed: 2002
Number of employees: 95

Regional and subsidiary offices

Cancer Research Technology Inc.
One Kendall Square
Bldg 200, 1st Floor
Cambridge
Massachusetts
02139
Massachusetts

Tel:  +1 617 225 0574
Fax: +1 617 577 1316
www | email

Related categories

Industry sector
Biotech
Diagnostic
Drug delivery
Pharmaceutical
Biotechnology / Assay systems
Biotechnology / Diagnostic test systems
Biotechnology / Gene therapy
Biotechnology / Human therapeutics
Biotechnology / Human diagnostics
Biotechnology / Research supplies
Drug discovery
Drug discovery / Genomics
Organizations
Technology transfer
Universities
Pharmaceutical / Prescription
Research tools / Antibodies
Research tools / Antigens
Research tools / Cell lines
Research tools / Mouse models
Research tools / Reagents
Marketing
Therapeutic target
Oncology
Oncology / Bladder cancer
Oncology / Bone cancer
Oncology / Brain cancer
Oncology / Breast cancer
Oncology / Cervical cancer
Oncology / Colorectal cancer
Oncology / Colorectal cancer
Oncology / Colorectal cancer
Oncology / Liver cancer
Oncology / Lung cancer
Oncology / Lymphoma
Oncology / Ovarian cancer
Oncology / Prostate cancer
Oncology / Skin cancer
Oncology / Testicular cancer
Oncology / Tumor (other)
Oncology / Cancer (other)
Oncology / Anti-oxidant
Oncology / Skin cancer / Basal cell carcinoma
Oncology / Prostate cancer / Benign prostatic hypertrophy
Oncology / Cancer side effects / Chemotherapy side effects
Oncology / Cancer side effects / Edema
Oncology / Womb cancer / Endometrial cancer
Oncology / Lung cancer / Malignant mesothelioma
Oncology / Skin cancer / Melanoma
Oncology / Womb cancer / Uterine cancer
Oncology / Treatments / Vaccines
Oncology / Treatments / Chemotherapy
Oncology / Treatments / Radiotherapy
Oncology / Leukemia / Acute myeloid leukemia
Partnering consultation free of charge
Bio-Europe 2008
Profile your company today
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us